Polybrominated diphenyl ethers (PBDEs)
|
Testicular cancer
|
US
|
81.5 [24.8–109.3]
|
<0.01
|
<0.01
|
EU
|
1100 [416–1100]
|
<0.01
|
<0.01
|
Cryptorchidism
|
US
|
35.7 [NA - NA]
|
<0.01
|
<0.01
|
EU
|
172.6 [155.5–172.6]
|
<0.01
|
<0.01
|
Dichlorodiphenyl trichloroethane (DDE)
|
Childhood obesity
|
US
|
29.6 [NA - 57.3]
|
<0.01
|
<0.01
|
EU
|
32.7 [NA - 114.8]
|
<0.01
|
<0.01
|
Adult diabetes
|
US
|
1800 [NA – 13,500]
|
<0.01 [NA - 0.08]
|
<0.01
|
EU
|
1100 [NA – 22,065]
|
<0.01 [NA - 0.13]
|
<0.01
|
Fibroids
|
US
|
259 [NA - NA]
|
<0.01
|
<0.01
|
EU
|
216.8 [NA - NA]
|
<0.01
|
<0.01
|
Di-2-ethylhexyl phthalate
|
Adult obesity
|
US
|
1700 [NA - NA]
|
0.011
|
<0.01
|
EU
|
20,800 [NA - NA]
|
0.12
|
<0.01
|
Adult diabetes
|
US
|
91.4 [NA - NA]
|
<0.01
|
<0.01
|
EU
|
807.2 [NA - NA]
|
<0.01
|
<0.01
|
Endometriosis
|
US
|
47,000 [NA - NA]
|
0.32
|
<0.01
|
EU
|
1700 [NA - NA]
|
0.01
|
<0.01
|
Bisphenol A
|
Childhood obesity
|
US
|
2400 [NA - NA]
|
0.02
|
<0.01
|
EU
|
2000 [NA - NA]
|
0.02
|
<0.01
|
Benzyphtalates & butylphalates
|
Male infertility resulting in Increasesed ART
|
US
|
2500 [NA - NA]
|
0.02
|
<0.01
|
EU
|
6300 [NA - NA]
|
0.04
|
0.01
|
Phtalates
|
Low testoterone and increased early mortality
|
US
|
8800 [NA - NA]
|
0.06
|
0.012
|
EU
|
10,600 [NA - NA]
|
0.05
|
0.012
|
Multiple exposures
|
Attention deficit hyperactivity disorder (ADHD)
|
US
|
698 [568–1950]
|
<0.01 [<0.01–0.011]
|
<0.01
|
EU
|
3056 [1600–3800]
|
0.014 [<0.01–0.017]
|
<0.01
|
Autism
|
US
|
1984 [803–4100]
|
0.014 [<0.01–0.024]
|
<0.01
|
EU
|
352 [105–530]
|
<0.01
|
<0.01
|
All compounds included
| |
US
|
340,000 [668–612,000]
|
2.33 [<0.01–3.53]
|
0.54 [<0.01 0.96]
|
|
EU
|
217,000 [110,049–359,239]
|
1.2 [0.75–2.12]
|
0.34 [0.17–0.57]
|
|
Sum
|
557,000 [110,707–971,239]
|
1.8 [0.3–3.07]
|
0.88 [0.17–1.54]
|